Stopping a GLP-1 medicine: what happens to your weight?
Made with AI tools and overseen by an Australian GP · Updated 8 November 2026
The awkward truth that social media skips: these medicines treat weight while you take them. Stop, and appetite usually comes back, and so does much of the weight.
Quick answer: Most people regain weight after stopping. A year after stopping semaglutide, people in the STEP 1 extension had regained about two-thirds of the weight they’d lost. In SURMOUNT-4, people switched from tirzepatide to placebo regained 14% of their weight in a year, while those who continued kept losing. Plan any stop with your doctor.
What the trials found
- STEP 1 extension (semaglutide): people lost 17.3% of their weight over 68 weeks. One year after stopping, they’d regained 11.6 percentage points, leaving them 5.6% below their starting weight.
- STEP 4 (semaglutide): after 20 weeks on treatment (10.6% lost), people who continued lost a further 7.9% over 48 weeks. Those switched to placebo regained 6.9%.
- SURMOUNT-4 (tirzepatide): after 36 weeks (20.9% lost), people who continued lost a further 5.5% over a year. Those switched to placebo regained 14.0%.
- In SURMOUNT-4, 89.5% of people who stayed on tirzepatide kept at least 80% of their weight loss, versus 16.6% on placebo.
Health benefits fade too
- In the STEP 1 extension, improvements in blood pressure, blood fats and blood sugar mostly drifted back towards where they started once semaglutide stopped.
- If you have diabetes, your blood sugar may rise again, so your doctor may need to adjust your other treatment.
Why it happens
- Obesity is a long-term (chronic) condition. The trial authors concluded that ongoing treatment is needed to keep the weight and health gains.
- Regain after stopping isn’t a willpower failure. It’s what the medicine stopping looks like.
- One caveat: in the STEP 1 extension, the lifestyle support also stopped at the same time.
If you’re thinking of stopping
- Talk to your doctor first, so you can plan follow-up checks of weight, blood pressure, blood sugar and cholesterol.
- Keep up strength training and protein: muscle helps you stay strong whatever the scales say. See muscle loss and protein.
- Planning a pregnancy? There are minimum gaps before trying to conceive. See pregnancy and contraception.
See your GP before stopping if you take a GLP-1 medicine for type 2 diabetes, so your blood sugar plan can be adjusted. Get urgent help (000 in Australia, or your local emergency number) for very high blood sugar with vomiting, drowsiness or confusion.
Need a brain break? Play Dxtective, the daily diagnosis puzzle, or browse all medical games. Free, no sign-up.
Common questions
Will I regain all the weight if I stop?
Not necessarily all of it, but most people regain a lot. One year after stopping semaglutide in the STEP 1 extension, people had regained about two-thirds of their lost weight and were 5.6% below their starting weight on average.
How fast does weight come back after stopping Mounjaro?
In SURMOUNT-4, people switched from tirzepatide to placebo regained 14% of their body weight over the following year.
Do the health benefits go away when I stop?
Mostly, yes. In the STEP 1 extension, improvements in blood pressure, blood fats and blood sugar largely went back towards where they started within a year of stopping.
Do I have to take a GLP-1 medicine forever?
Not necessarily, but the trials show the benefits last only while you take it. How long to continue is a decision to make with your doctor, weighing benefits, side effects and cost.
Is regaining weight my fault?
No. Regain after stopping is expected from how these medicines work: appetite returns when the medicine stops. It happened to most people in carefully run trials.
Evidence and more information
- Wilding et al, Diabetes, Obesity and Metabolism 2022: STEP 1 trial extension, weight regain after stopping semaglutide
- Rubino et al, JAMA 2021: STEP 4, continuing versus stopping semaglutide
- Aronne et al, JAMA 2024: SURMOUNT-4, continuing versus stopping tirzepatide
- Wilding et al, NEJM 2021: STEP 1, semaglutide 2.4 mg for weight management (weight loss, side-effect and gallbladder rates)
maladywise.com/glp-1/stopping/